Nanosonics (ASX: NAN)
Nanosonics Ltd. engages in the research, development, and commercialization of infection control and decontamination products and related technologies. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia.
Fundamentals Nanosonics
Last updated May 14, 2026, 02:00:00am EDTRecommendations
Could not find any current recommendations for this ticker.
All Coverage
Could not find any coverage about the current ticker.